Pear Therapeutics, Inc. Quarterly Assets, Current in USD from Q4 2020 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Pear Therapeutics, Inc. quarterly Assets, Current history and growth rate from Q4 2020 to Q4 2022.
Pear Therapeutics, Inc. Assets, Current for the quarter ending December 31, 2022 was $73M, a 60.6% decline year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$73M	-$112M	-60.6%	Dec 31, 2022	10-K	2023-03-31
Q3 2022	$98.9M	+$97.9M	+9748%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$121M	+$119M	+6758%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$150M	+$149M	+11049%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$185M	+$59.2M	+47%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$1M			Sep 30, 2021	10-Q	2021-11-05
Q2 2021	$1.76M			Jun 30, 2021	10-Q	2021-08-19
Q1 2021	$1.35M			Mar 31, 2021	10-Q	2021-05-24
Q4 2020	$126M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.